darifenacin


Also found in: Medical, Wikipedia.
Related to darifenacin: Tolterodine, darifenacin hydrobromide
Translations

darifenacin

n darifenacina
References in periodicals archive ?
The anticholinergics segment has been further sub-segmented into solifenacin, oxybutynin, fesoterodine, darifenacin, tolterodine, trospium, and others.
Darifenacin (Enablex), fesoterodine (Toviaz), flavoxate (Urispas), oxybutynin (Ditropan), solifenacin (Vesicare), tolterodine (Detrai), and trospium (Sanctura).
Incontinence Drugs: Darifenacin, Flavoxate, Oxybutynin, Tolterodine,
Basic characteristics of the antimuscarinic drugs Darifenacin 507.5 Low M3 Fesoterodine 527.6 Low Non-selective Oxybutynin 393.9 High Non-selective Propiverine 403.9 (*) Limited data Non-selective Solifenacin 480.5 Moderate Predominantly M3 Tolterodine 475.6 Moderate Non-selective Trospium 427.9 Low Non-selective BBB: Blood-brain barrier, (*) Value expressed in g/moL Table 2.
Darifenacin (Enablex[R]) is an anticholinergic medication used to treat overactive bladder and urge incontinence.
(6) Currently in Canada there are six anticholinergic drugs approved for treatment of OAB symptoms: darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine and trospium.
Darifenacin, mirabegron, oxybutynin ER, solifenacin, tolterodine, and trospium were classified as FORTA C (Questionable; Caution), while oxybutynin IR and propiverine were classified as FORTA D (Avoid; Do not).
The aim of this study was to prove the in vivo efficacy of Gegen on improving detrusor overactivity and its possible synergism with darifenacin (a first-line muscarinic receptor-3 inhibitor) in spontaneously hypertensive rats (SHR), a rat model exhibiting symptoms of detrusor overactivity.
Furthermore, new-generation anticholinergic agents, such as darifenacin and solifenacin, are selective for the M3 receptor and thus offer the potential of reduced side-effects.
Newer anticholinergics approved for treatment of OAB include solifenacin (VESIcare[R]), darifenacin (Enablex[R]), and fesoteradine fumarate (Toviaz[R]) (Nabili, 2013).
Medications for Overactive Bladder (OAB) DRUG BRAND(S) RECOMMENDED ORAL DOSE Darifenacin Enablex 7.5 mg once daily.
* Solifenacin (Vesicare) and darifenacin (Enablex).